DCT

1:20-md-02930

In re: Entresto (Sacubitril/Valsartan) Patent Litigation

General
Filed
03/27/20
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company (W)
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
36%